Showing results (4351-4360 of 6,795) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|July 7, 2001
Meta-analysis comparing newer antipsychotic drugs for the treatment of schizophrenia: evaluating the indirect approachL Sauriol, M Laporta, M D Edwardes, et al.Clinical Therapeutics|July 7, 2001
The effects of postal and telephone reminders on compliance with pravastatin therapy in a national registry: results of the first myocardial infarction risk reduction programR M GuthrieClinical Therapeutics|October 26, 2000
Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0-mL prefilled pen device for insulin deliveryN J Bohannon, J P Ohannesian, A L Burdan, et al.Clinical Therapeutics|October 26, 2000
The discriminative ability of the 12-item short form health survey (SF-12) in a sample of persons infected with HIVT Delate, S J CoonsClinical Therapeutics|December 16, 2000
Effect of zanamivir on duration and resolution of influenza symptomsA S Monto, A B Moult, S J SharpClinical Therapeutics|December 16, 2000
Indirect cost of HIV infection in EnglandC D Mullins, G Whitelaw, J L Cooke, et al.Clinical Therapeutics|September 6, 2000
Dose-response effect of combination hydrocodone with ibuprofen in patients with moderate to severe postoperative painM Palangio, G L Wideman, M Keffer, et al.Clinical Therapeutics|June 9, 2001
Pharmacokinetic profiles of current therapies for Alzheimer's disease: implications for switching to galantamineM R FarlowClinical Therapeutics|November 16, 2019
Ezetimibe and Rosuvastatin Combination Treatment Can Reduce the Dose of Rosuvastatin Without Compromising Its Lipid-lowering EfficacyMoo-Yong Rhee, Kyung-Jin Kim, Sang-Hyun Kim, et al.Clinical Therapeutics|December 9, 2019
Utility of Therapeutic Drug Monitoring of Imatinib, Nilotinib, and Dasatinib in Chronic Myeloid Leukemia: A Systematic Review and Meta-analysisManuel García-Ferrer, Aneta Wojnicz, Gina Mejía, et al.Pageof 680